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Background:  Protein losing enteropathy (PLE) is a challenging complication after Fontan operation (FO). PLE may develop over a wide 
time course, ranging from days to decades after FO. Sub-clinical enteric protein loss (EPL) in which stool protein levels are elevated but not 
to the extent to cause hypoalbuminemia and edema may be common after FO and may precede development of clinical PLE. We sought to 
determine the acute effects of Fontan circulation on EPL and mesenteric vascular resistance.
methods:  A prospective longitudinal study was performed. EPL was evaluated through stool alpha-1-antitrypsin (A1AT) concentration, 
and intestinal circulation was characterized by Doppler derived resistance indices of the superior mesenteric artery (SMA). Serum albumin 
levels were also obtained. Assessments were performed before FO and acutely after FO. Post FO data were collected when the patient 
met earliest criteria of wellness (>4 days post FO, spontaneously breathing, not receiving inotropic support, and taking enteric feeds).
results:  We enrolled 31 subjects (27 M, 4 F). In most (n=29), the Fontan type was fenestrated extracardiac. Median age at FO was 3.0 
years (IQR 2.5-3.3). Pre FO study was performed 9 days (IQR 2-36) prior to surgery, and post FO study 6 days (IQR 5-8) after surgery. No 
clinical PLE was observed. Abnormal A1AT (> 54 mg/dl) was present in 2 subjects pre FO and in 2 different subjects post FO. One subject 
with abnormal A1AT at each time point had unique and significant hemodynamic disturbance (junctional bradycardia or tricuspid stenosis 
after valvuloplasty). There was no difference in SMA resistance indices pre versus post FO. Albumin (mg/dl) was lower post FO compared 
to pre FO (3.2[0.5] vs 3.8[0.7], p=.0008) but did not correlate with abnormal A1AT or with SMA resistance indices.
Conclusion:  Imposition of a Fontan circulation does not commonly result in acute development of EPL. However, EPL may occur before 
or after FO particularly when hemodynamic disturbances are present, which suggests an inherent association with single ventricle defects. 
Serial stool A1AT evaluation post FO may better delineate the time course of development of EPL or possible progression to PLE in at-risk 
patients.
